- Home
- SNX vs RGEN Comparison
SNX vs RGEN Comparison
Compare SNX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNX
- RGEN
- Stock Information
- Founded
- SNX 1980
- RGEN 1981
- Country
- SNX United States
- RGEN United States
- Employees
- SNX N/A
- RGEN N/A
- Industry
- SNX Retail: Computer Software & Peripheral Equipment
- RGEN Medical/Dental Instruments
- Sector
- SNX Technology
- RGEN Health Care
- Exchange
- SNX Nasdaq
- RGEN Nasdaq
- Market Cap
- SNX 9.5B
- RGEN 8.2B
- IPO Year
- SNX 2003
- RGEN N/A
- Fundamental
- Price
- SNX $115.71
- RGEN $136.22
- Analyst Decision
- SNX Buy
- RGEN Buy
- Analyst Count
- SNX 9
- RGEN 10
- Target Price
- SNX $127.33
- RGEN $188.38
- AVG Volume (30 Days)
- SNX 451.0K
- RGEN 783.2K
- Earning Date
- SNX 09-26-2024
- RGEN 10-29-2024
- Dividend Yield
- SNX 1.41%
- RGEN N/A
- EPS Growth
- SNX 1.47
- RGEN N/A
- EPS
- SNX 7.13
- RGEN N/A
- Revenue
- SNX $56,291,082,000.00
- RGEN $602,354,000.00
- Revenue This Year
- SNX $0.53
- RGEN $0.08
- Revenue Next Year
- SNX $5.31
- RGEN $12.97
- P/E Ratio
- SNX $15.96
- RGEN N/A
- Revenue Growth
- SNX N/A
- RGEN N/A
- 52 Week Low
- SNX $89.73
- RGEN $110.45
- 52 Week High
- SNX $133.85
- RGEN $211.13
- Technical
- Relative Strength Index (RSI)
- SNX 51.72
- RGEN 37.10
- Support Level
- SNX $107.84
- RGEN $138.80
- Resistance Level
- SNX $123.17
- RGEN $150.72
- Average True Range (ATR)
- SNX 2.48
- RGEN 5.27
- MACD
- SNX -0.20
- RGEN -1.23
- Stochastic Oscillator
- SNX 51.34
- RGEN 1.94
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and datacenter infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include, the Americas, Europe, and APJ.
About RGEN Repligen Corporation
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.